Lataa...
A tale of two pities: Autologous melanoma vaccines on the brink
This paper reviews and compares two autologous vaccine technologies for human melanoma that failed to obtain marketing approval after 10–15 y of clinical development—the HSP vaccine invented by Srivastava and developed by the company, Antigenics, and the hapten-modified cellular vaccine invented by...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3551891/ https://ncbi.nlm.nih.gov/pubmed/22854662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.20923 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|